Smith Cynthia
- SEC CIK
- 0001609480
No open-market purchases or sales filed in the past year.
Current role at each company
- SPRO Spero Therapeutics, Inc.Directoras of Jun 25, 2026
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- AKBA Akebia Therapeutics, Inc.Directoras of Jun 22, 2026
- TARA Protara Therapeutics, Inc.Directoras of Jun 16, 2026
- TVRD Tvardi Therapeutics, Inc.Directoras of Jun 11, 2026
Show 1 more company
- DRNA Dicerna Pharmaceuticals IncDirectoras of Dec 29, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Cynthia as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
No insider trades match these filters.